BELVIN MARCIA
Insider CIK 1970752 · CTMX SVP, Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTMX CytomX Therapeutics, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 31,492 | $6.42 | $202.2K | 300,760 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-04 | 60,000 | — | $0 | 332,252 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-09-26 | 2025-09-30 | 36,300 | — | $0 | 36,300 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-09-26 | 2025-09-30 | 18,150 | — | $0 | 18,150 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2025-06-16 | 2025-06-17 | 13,884 | $2.69 | $37.3K | 272,252 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 286,136 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2025-03-18 | 2025-03-20 | 19,512 | $0.60 | $11.7K | 248,636 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-10 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-06 | 57,500 | — | $0 | 263,148 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-06 | 30,000 | — | $0 | 205,648 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-10 | 35,000 | — | $0 | 210,648 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-10 | 57,500 | — | $0 | 268,148 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2024-08-20 | 2024-08-22 | 4,181 | $1.23 | $5.1K | 175,648 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 179,829 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2024-03-19 | 2024-03-21 | 12,795 | $2.09 | $26.7K | 168,579 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-19 | 122,500 | — | $0 | 122,500 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2024-01-18 | 2024-01-19 | 26,250 | — | $0 | 181,374 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2023-12-20 | 2023-12-22 | 4,077 | $1.38 | $5.6K | 155,124 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 11,250 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 159,201 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2023-09-22 | 2023-09-22 | 4,119 | $1.30 | $5.4K | 147,951 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2023-09-20 | 2023-09-22 | 11,250 | — | $0 | 152,070 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2023-03-22 | 2023-03-29 | 60,000 | — | $0 | 140,820 | SEC↗ |